Patient Awareness and Understanding of Intrauterine Devices

Similar documents
International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Long-Acting Reversible Contraception: The Contraceptive CHOICE Project

Unintended Pregnancy in U.S. The Importance of LARC: What have We Learned? Long-acting Reversible Contraception (LARC)

2

Click to edit Master title style. Unintended Pregnancy: Prevalence. Unintended Pregnancy: Risk Groups. Unintended Pregnancy: Consequences 9/23/2015

Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion

International Federation of Gynecology and Obstetrics

Addiction Burden and Resources for Patients in Connecticut

Maximizing LARC Availability: Bringing the Lessons of the CHOICE Project to Your Community

Adolescent pregnancies have declined

Intrauterine Devices (IUDs): Access for Women in the U.S.

Global Contraception

Long-Acting Reversible Contraception (LARC): State-Level and Regional Research on Reducing Barriers to Access

Healthy Texas Women 1115(a) Medicaid Demonstration Waiver Application

UCSF UC San Francisco Previously Published Works

Improving IUD Usage Among Adolescents Through Provider Education

The most commonly chosen methods of contraception

Permanent Sterilisation to Long-Acting Reversible Contraception: Is a Paradigm Shift Necessary?

What s New in Adolescent Contraception?

Emergency Contraception THE FACTS

Simplifying Vide Contraception. University of Utah Department of Ob/Gyn Post Grad Course February 13, 2017 David Turok

Birth Control- an Overview. Keith Merritt, MD. Remember, all methods of birth control are safer and have fewer side effects than pregnancy

BRIEF REPORTS. Providing Long-Acting Reversible Contraception in an Academic Family Medicine Center Jennifer Amico, MD, MPH; Justine Wu, MD, MPH

Our Moment of Truth TM

According to data from the 2006 to 2008 National Survey

Patient or Clinician: Duration of Use of Intrauterine Devices Based on Who Initiated Discussion of Placement

Influenza Awareness in Berlin and Montpelier, VT

Test Your Knowledge: STI Questionnaire and Education

PREVENTING PREGNANCY: TALKING ABOUT AND USING CONTRACEPTION

Long Acting Reversible Contraception: First Line Care for Adolescents. David A. Levine, MD, FAAP Melissa Kottke, MD, MPH, FACOG

VCHIP LARC Needs Assessment Survey

Our Moment of Truth 2013 Survey Women s Health Care Experiences & Perceptions: Spotlight on Family Planning & Contraception

Tips for Successfully Managing Your Type 2 Diabetes

Alcoholism Self Assessments, Thomas Chittenden Health Center

Unintended Pregnancy is Common LEARNING OBJECTIVES. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy And Contraceptive Use

Fighting the flu - Devising a novel approach to address patient concerns with the seasonal influenza vaccine - South Burlington, VT

LEARNING OBJECTIVES. Beyond the Pill: Long Acting Contraception. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy is Common

Contraception Choices: An Evidence Based Approach Case Study Approach. Susan Hellier PhD, DNP, FNP-BC, CNE

RESOLUTION NO. 301 (Co-Sponsored G) SUBSTITUTE ADOPTED See Below

Contraception for Adolescents: What s New?

Disclosures. Learning Objectives 4/18/2017 ADOLESCENT CONTRACEPTION UPDATE APRIL 28, Nexplanon trainer for Merck

Adolescent Sex Education

Improving Annual Influenza Vaccination Through Patient Education

An Overview of Long Acting Reversible Contraception Methods

The Facts - Your Choice: STD Risk Information for the Adolescent Patient

Assessing Access to Smoking Cessation Resources in Rural Populations

Understanding Racial and Ethnic Differentials in Contraceptive Use Patterns in the Contemporary United States

The Intrauterine Device in Women of Childbearing Age Has A Greater Long-Term Cost-Benefit than Oral Contraception Pills

Prescriber Guide for the Letairis REMS Program

ASSESSMENT OF FACTORS AFFECTING UTILIZATION OF LONG ACTING REVERSIBLE CON- TRACEPTIVES IN HURUMA SUB-COUNTY HOSPITAL, UASIN GISHU COUNTY, KENYA

A Teacher s Guide Sexually

Promoting Public Water Fluoridation in Bennington VT

Lindsey Tingen, MD Department of Obstetrics and Gynecology, Greenville Health System Greenville, SC

Instruction for the patient

Contraception and birth control

Long Acting Reversible Methods of Contraception (LARC) in Scotland

Same-Day Access to Highly Effective Reversible Contraception: Moving from Plan B to Happily Ever After

Educating High School Students on the Negative Health Effects of Vaping

Increasing Patient Understanding & Provider Awareness of Pap Smears

Increasing the Proportion of Women using Long Acting Reversible Contraception (LARC) within a Geographical Area in Scotland

Pull and pray or extra protection? Contraceptive strategies involving withdrawal among US adult women

Long-Acting Reversible Contraceptives In Vermont: A Survey Based Assessment Of Current Knowledge Of Providers Of Women Of Reproductive Age

Preventing Falls in the Elderly

Contraceptive Technology, 18th Revised Edition By James Trussell, Robert A. Hatcher

Dietary Supplement Education in a Primary Care Setting

Vitamin D Screening and Supplementation

2

Barriers to recovery for Buprenorphine Patients in Bangor, Maine

Creating an Effective Education Pamphlet on Sun Protection and Skin Cancer Prevention

Application for inclusion of levonorgestrel - releasing IUD for contraception in the WHO Model List of Essential Medicines

Effective Contraception Utilization. Sarah Laiosa, DO Family Physician Contract Medical Director, EOCCO

Temporal Trends - Original

Adolescent Experiences With Intrauterine Devices: A Qualitative Study

Unintended pregnancies are a difficult public health problem

Contraceptives. Kim Dawson October 2010

Optimizing Inhaler Technique

Long Acting Reversible Methods of Contraception (LARC) Key Clinical Indicator

Long Acting Reversible Methods of Contraception (LARC) Key Clinical Indicator

HPV Vaccination: Educating and Empowering the Next Generation

the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD your guide to

LARC: Disclosures. Long Acting Reversible Contraception. Objectives 10/23/2013. I have no relevant financial disclosures

Perceived and Insurance-Related Barriers to the Provision of Contraceptive Services in U.S. Abortion Care Settings

Intrauterine Devices and Pelvic Inflammatory Disease: Dispelling the Myth. Dr Amy Moten SHine SA Co-authors: Dr Richelle Douglas; Dr Alison Creagh SHQ

The Pennsylvania State University. The Graduate School. Department of Public Health Sciences

Welcome to Mirena. The Mirena Handbook: A Personal Guide to Your New Mirena. mirena.com. Mirena is the #1 prescribed IUD * in the U.S.

Contraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016

Indonesia and Family Planning: An overview

Prescriber and Pharmacy Guide for the Opsumit REMS Program

Diet Management for Adult Onset Diabetes Mellitus Type 2

Informed Consent Flipchart. Version 1.0, 30 Jan 2018

Monitoring MDG 5.B Indicators on Reproductive Health UN Population Division and UNFPA

The number of women using long-acting reversible

levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer

Dr. Russo reports no financial relationships relevant to this article. Dr Creinin is a senior clinical advisor for Medicines360.

Identification of Barriers to Organ Donation: A Primary Care Interventional Approach

Family Medicine Clerkship Student Projects

Lyme Disease: Prevention, Recognition & Treatment

Patient Education on the Association of Hormonal Contraception with Depression

Notes to Teacher continued Contraceptive Considerations

Transcription:

University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2016 Patient Awareness and Understanding of Intrauterine Devices Lindsey Marie Eastman University of Vermont College of Medicine Follow this and additional works at: https://scholarworks.uvm.edu/fmclerk Part of the Medical Education Commons, and the Primary Care Commons Recommended Citation Eastman, Lindsey Marie, "Patient Awareness and Understanding of Intrauterine Devices" (2016). Family Medicine Block Clerkship, Student Projects. 187. https://scholarworks.uvm.edu/fmclerk/187 This Book is brought to you for free and open access by the College of Medicine at ScholarWorks @ UVM. It has been accepted for inclusion in Family Medicine Block Clerkship, Student Projects by an authorized administrator of ScholarWorks @ UVM. For more information, please contact donna.omalley@uvm.edu.

Patient Awareness and Understanding of Intrauterine Devices Brookfield Family Medicine Brookfield, CT LINDSEY EASTMAN, MSIII UNIVERSITY OF VERMONT COLLEGE OF MEDICINE JULY/AUGUST 2016 PROJECT MENTORS: DR. CORNELIUS FERREIRA, DR. MARTHA MOULTON, DR. LAURIE SCHEDGICK-DAVIS

Problem Identification 2A Intrauterine devices (IUDs) are used by 14.3% of women and are currently the leading form of reversible contraception worldwide, but their use has historically been low in the United States. In 2011, IUDs were used by 17.9% of women in Asia, 12.4% in Europe, and 5.3% in the United States. 1,2 IUDs have a tumultuous history; their decreased popularity in the United States is likely attributed to the removal of the Dalkon Shield IUD from the market in 1974 due to an association with pelvic inflammatory infections. 3 Newly introduced long-acting reversible contraception methods, including implants and safer IUDs, are some of the most effective forms of birth control, have few contraindications, and very low rates of pelvic inflammatory infections. 4,5,6 IUD use has significantly increased in the United States in the 21 st century; prevalence of use increased from 7.7% to 10.3% in contraception users between 2009 and 2012. 7 Studies have shown that increasing knowledge about long-acting reversible contraception methods leads to more acceptance of IUDs and decreased pregnancy rates. 8,9,10

Identifying Need for IUD Educational Resources at Brookfield Family Medicine 2B Developed a 13 question survey to identify need for IUD educational resources at Brookfield Family Medicine Distributed survey to female patients between the ages of 18 and 50 to assess awareness and understanding of IUDs Survey included demographic data on age, contraception history, and obstetrical history Survey assessed knowledge of 5 aspects of IUDs: 1. Risk of uterine perforation with placement 2. Efficacy in preventing pregnancy 3. Length of time of efficacy 4. Effect on future fertility 5. Awareness of both hormonal and non-hormonal IUD methods Assessed perception of IUD safety for most of the population

Public Health Cost of Unintended Pregnancy 3 About 49% of pregnancies in the United States are unintended and teenage pregnancy rates are about 7 times higher than in other developed nations. 11 53% of unintended pregnancies are attributed to imperfect contraception use. 12 Historically, the price of long-acting reversible birth control methods impeded their accessibility, but the Affordable Care Act has increased access to such highly effective contraception methods. Total cost of unintended pregnancy in the US estimated at $21 billion in 2010; total cost in Connecticut was $208.5 million. 13 Total cost of unintended pregnancy is higher in Connecticut than the national average; cost was $301 per woman aged 15-44 in Connecticut compared to $201 per woman nationally. 13 Trussell et. al. estimates that if 10% of women in the United States ages 20-29 switched from short-acting reversible contraception methods to long-acting reversible methods, such as the IUD or implant, $288 million in health care costs would be reduced annually. 12

Provider Perspective on IUDs in Connecticut 4A Anne McDermott, CNM, MSN, Certified Nurse Midwife at Norwalk Community Health Center The rate of pregnancy is so much lower than with the pill, condoms, or the depo-provera. We are trying to educate patients about it [the IUD] and encourage to use it. There is a lot of misinformation about intrauterine devices. Common patient concerns about the IUD include that they won t be able to get pregnant after they get it taken out feel like getting their period is a sign of good health, and that they could be pregnant and not know it. Dr. Mishal Mirza, MD, OBGYN at Danbury Hospital There is more awareness and acceptance of IUDs than previously. Common misconceptions are related to infertility; some patients have expressed concern that having an IUD will negatively impact future fertility. Other patients have voiced concern that an IUD may be painful while in place, will not be able to be removed, that their partner would be able to feel it during intercourse, or that it will have adverse hormonal effects. Several populations are ideal for IUDs as a contraceptive method, including young women in their late teens and twenties, women who experience menorrhagia, and women who have already had children but have not yet entered menopause. Both providers agreed that the public could benefit from more education on IUDs.

% Correct of Knowledge Questions Survey Results: Patient Perspective at 4B Brookfield Family Medicine N = 43 surveys were collected from female patients between the ages of 18 and 50 at Brookfield Family Medicine Calculated total score of correct knowledge questions out of 5 12% of patients did not know what an IUD is 50% of patients learned about IUDs from professionals (including physicians, nurses, and teachers) When given a choice between birth control pills (BCPs), condoms, IUDs, and the birth control patch, 40% of patients believed birth control pills (BCPs) to be the most efficacious in preventing pregnancy, compared to 34% IUDs and 26% condoms Most patients believed risk of uterine perforation with placement to be higher than actual risk (< 1%): 23% believed 35/100 placements result in perforation 46% believed 10/100 placements result in perforation Two-tailed T-Test revealed a significant difference in knowledge about IUDs and perceived safety of the devices (P = 0.04, mean score of those who perceived safe = 64%, mean score of those who perceived unsafe = 34%) ANOVA between age and knowledge revealed a significant negative correlation (significance F = 0.044) 100 80 60 40 20 0 IUD Knowledge +/- 1 SD 18-20 21-30 31-40 41-50 Age Range (years)

Intervention and Methodology 5A Intervention: Survey results suggested that a physician s office may be an effective site for educational intervention as most patients learned about IUDs from professionals. Created a trifold pamphlet that includes descriptions and efficacy of birth control methods to be distributed to women interested in contraception at Brookfield Family Medicine and to be displayed around the office. Developed an algorithm included in the pamphlet to highlight some of the major distinctions between methods with the goal of helping patients chose a contraception that best fits their lifestyle and personal goals. Methodology: Interviewed local women s health providers to understand common concerns and misconceptions about IUDs and included information to address these common concerns in the contraception pamphlet. Reviewed Planned Parenthood website for details on different contraception options and efficacy rates in preventing pregnancy. Information on all types of contraception included as IUDs may not be the best birth control method for everyone. Goal is to increase knowledge and acceptance of IUDs through inclusion in information about all types of birth control. Distribution and display at a Family Medicine office will target a large population, including adolescents, and will allow birth control information to be routinely provided to patients in a sustainable format.

Contraception Method Patient Pamphlet 5B

Response from Providers 6 The project, survey results, and goal to increase knowledge of IUDs and other contraception options were presented to all of the physicians and practitioners at Brookfield Family Medicine during a provider meeting Providers were given copies of the pamphlet to review and it was positively received All providers believed that the pamphlet will be a helpful tool for contraception discussions with patients Some providers plan to display the pamphlet in their patient rooms so contraception information is available to patients waiting to be seen; others plan to distribute it at health maintenance exams for female patients of a designated age group Electronic copies of the handout were provided to staff for future use and distribution

Evaluation of Effectiveness and Limitations 7 Evaluation of Effectiveness: Effectiveness of pamphlet providing information on IUDs could be assessed with distribution of a postintervention survey at Brookfield Family Medicine that includes the 5 knowledge questions assessed in the survey of this project Effectiveness of the pamphlet communicating information about all types of birth control could be assessed if instituted in another Family Medicine office with a pre-distribution and post-distribution survey to assess if more knowledge was gained after pamphlets were distributed Limitations: Providing information on all methods of birth control in pamphlet for it to be a more versatile tool limited the amount of details that could be included specifically about intrauterine devices This project was restricted to the population of patients who attend a single Family Medicine office in Brookfield, CT and may not accurately reflect a larger population

Recommendations for the Future 8 Assess effectiveness of the pamphlet in increasing awareness of IUDs, specifically in women ages 30 to 50, as this age group was less knowledgeable about IUDs than younger patients based on our survey results Encourage providers to discuss contraception options with women during all routine health maintenance exams Standardize the pamphlet for other Family Medicine offices within the Western Connecticut Health Network to be displayed within the office or distributed at health maintenance exams Integrate the pamphlet into the electronic medical record system to be automatically printed with visit summary information for female patients of a designated age group

References 9A 1. World Contraceptive Use 2011. http://www.un.org/esa/population/publications/contraceptive2011/contraceptive2011.htm. 2. Buhling KJ, Zite NB, Lotke P, Black K. Worldwide use of intrauterine contraception: a review. Contraception. 2014;89(3):162-173. doi:10.1016/j.contraception.2013.11.011. 3. Hubacher D. The checkered history and bright future of intrauterine contraception in the United States. Perspect Sex Reprod Health. 34(2):98-103. http://www.ncbi.nlm.nih.gov/pubmed/12043715. Accessed August 7, 2016. 4. Nelson AL. Contraindications to IUD and IUS use. Contraception. 2007;75(6):S76-S81. doi:10.1016/j.contraception.2007.01.004. 5. Winner B, Peipert JF, Zhao Q, et al. Effectiveness of Long-Acting Reversible Contraception. N Engl J Med. 2012;21366(24):1998-2007. 6. Papic M, Wang N, Parisi SM, Baldauf E, Updike G, Schwarz EB. Same-Day Intrauterine Device Placement is Rarely Complicated by Pelvic Infection. Women s Heal Issues. 2015;25(1):22-27. doi:10.1016/j.whi.2014.09.006. 7. Kavanaugh ML, Jerman J, Finer LB. Changes in Use of Long-Acting Reversible Contraceptive Methods Among U.S. Women, 2009 2012. Obstet Gynecol. 2015;126(5):917-927. doi:10.1097/aog.0000000000001094.

References (continued) 9B 8. Arrowsmith ME, Aicken CRH, Saxena S, Majeed A. Strategies for improving the acceptability and acceptance of the copper intrauterine device. Cochrane database Syst Rev. 2012;(3):CD008896. doi:10.1002/14651858.cd008896.pub2. 9. Harper CC, Rocca CH, Thompson KM, et al. Reductions in pregnancy rates in the USA with long-acting reversible contraception: a cluster randomised trial. Lancet. 2015;386(9993):562-568. doi:10.1016/s0140-6736(14)62460-0. 10. Secura GM, Madden T, McNicholas C, et al. Provision of no-cost, long-acting contraception and teenage pregnancy. N Engl J Med. 2014;371(14):1316-1323. doi:10.1056/nejmoa1400506. 11. Fox J, Barfield W, L R, et al. Decreasing Unintended Pregnancy. JAMA. 2016;312(8):785-786. doi:10.1001/jama.2016.8800. 12. Trussell J, Henry N, Hassan F, Prezioso A, Law A, Filonenko A. Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception. Contraception. 2013;87(2):154-161. doi:10.1016/j.contraception.2012.07.016. 13. Sonfield A, Kost K. Public Costs from Unintended Pregnancies and the Role of Public Insurance Programs in Paying for Pregnancy-Related Care National and State Estimates for 2010. 2015.